Carolina Alves

Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinoma

G. Le Teuff, B. Escudier, R. Flippot, 2020, Oncotarget.

Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma.

R. Flippot, L. Albiges, L. Derosa, 2022, Bulletin du Cancer.